Sr VP, CFO of Theravance Inc. (THRX, Financial) Michael W Aguiar sells 10,000 shares of THRX on 12/09/2011 at an average price of $21.86 a share.
Theravance Inc. has a market cap of $1.95 billion; its shares were traded at around $22.78 with and P/S ratio of 80.4.
For the complete insider trading history of THRX, click here.
Theravance Inc. has a market cap of $1.95 billion; its shares were traded at around $22.78 with and P/S ratio of 80.4.
Directors and Officers Recent Trades:
- 10% Owner Plc Glaxosmithkline bought 58,411 shares of THRX stock on 11/01/2011 at the average price of 22.23. Plc Glaxosmithkline owns at least 15,725,953 shares after this. The price of the stock has increased by 2.47% since.
- 10% Owner Plc Glaxosmithkline bought 102,466 shares of THRX stock on 08/02/2011 at the average price of 19.71. Plc Glaxosmithkline owns at least 15,667,542 shares after this. The price of the stock has increased by 15.58% since.
- Sr VP, Gen. Counsel, Secretary Bradford J Shafer sold 20,000 shares of THRX stock on 11/28/2011 at the average price of 21. Bradford J Shafer owns at least 353,423 shares after this. The price of the stock has increased by 8.48% since.
- Director Jeffrey M Drazan sold 4,293 shares of THRX stock on 11/28/2011 at the average price of 21. Jeffrey M Drazan owns at least 42,051 shares after this. The price of the stock has increased by 8.48% since.
For the complete insider trading history of THRX, click here.
